Vaccine News and Research

Latest Vaccine News and Research

NIH establishes a unified clinical trial network for testing COVID-19 vaccines

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.

8 Jul 2020

Tuberculosis vaccine may play a significant role in mitigating COVID-19 mortality rates

One of the emerging questions about the coronavirus that scientists are working to understand is why developing countries are showing markedly lower rates of mortality in COVID-19 cases than expected.

8 Jul 2020

Fred Hutch joins new clinical trials network to fight COVID-19

Fred Hutchinson Cancer Research Center has been named the coordinating center for vaccine clinical trials of the COVID-19 Prevention Network.

8 Jul 2020

Researchers isolate potent SARS-CoV-2 neutralizing antibodies

An important line of defense in the fight against the new coronavirus SARS-CoV-2 is the formation of neutralizing antibodies.

8 Jul 2020

ACS publishes updated guideline for HPV vaccination

The American Cancer Society has updated its guideline for HPV vaccination, adapting a 2019 update from the Federal Advisory Committee on Immunization Practices.

8 Jul 2020

Analysis: How a COVID-19 vaccine could cost Americans dearly

Yes, of course, Americans' health is priceless, and reining in a deadly virus that has trashed the economy would be invaluable.

8 Jul 2020

World's first clinical trial of immune-boosting strategy to protect cancer patients from COVID-19

In the race to find new ways to prevent and treat COVID-19, Canadian researchers have launched an innovative clinical trial focussed on strengthening the immune system for one of the most vulnerable populations - cancer patients.

8 Jul 2020

China reports Dengue fever after bubonic plague threat

The actively spreading coronavirus disease (COVID-19) first emerged in China in December 2019. More than six months after, the world grapples with nearly 11.8 confirmed cases of the viral infection. Now, as China slowly starts to reboot its economy and ease lockdown restrictions, two new health issues are emerging.

8 Jul 2020

Study of glycosylation on SARS-CoV-2 spike protein

The first intimation of the current COVID-19 crisis came with the news of severe pneumonic illness caused by an unknown agent in a Chinese city called Wuhan, issued on the last day of 2019. Following this, researchers found the cause to be a novel coronavirus, closely related to the earlier SARS virus, now called severe acute respiratory syndrome coronavirus 2.

8 Jul 2020

Many in the UK would refuse a coronavirus vaccine, survey finds

The novel coronavirus pandemic (COVID-19) has left many scientists and pharmaceutical companies racing to develop an effective vaccine to combat the viral infection. With 21 candidate vaccines in clinical evaluation, 139 candidate vaccines in preclinical evaluation across the world, most countries are hoping to be first to the post.

7 Jul 2020

Coronavirus study shows herd immunity is infeasible

Herd immunity has been one of the key topics amid the coronavirus pandemic. Previous reports show that when a large proportion of the population gets immune to the novel coronavirus, through vaccination, herd immunity can be achieved.

7 Jul 2020

Gene expression networks flag potential therapeutic targets for SARS-CoV-2

An international team of researchers from Canada, Australia, the Netherlands, and the United States has identified dozens of genes that could contribute to the pathology of coronavirus disease 2019 (COVID-19) and serve as potential therapeutic targets.

7 Jul 2020

Early life exposure to influenza shapes our susceptibility to future infections

Early infections of influenza A can help predict how the virus will affect people across different ages in the future and could impact the effectiveness of flu vaccines, says a new study published today in eLife.

7 Jul 2020

Life beyond COVID seclusion: Seniors see challenges and change ahead

Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."

7 Jul 2020

Spike proteins of SARS-CoV-2 covered by mobile glycans that shield its surface

A new study of the structural dynamics of the SARS-CoV-2 spike protein published in the preprint server bioRxiv in July 2020 reports on the epitopes that could be possible immune targets for the development of vaccines.

7 Jul 2020

SARS-CoV-2 spike protein hidden as pH changes

Now, a new study published on the preprint server bioRxiv in July 2020 reports the role of pH in helping the virus escape neutralization by antibodies, by inducing a key conformational switch.

7 Jul 2020

People find non-round numbers unique and jarring, shows research

A vaccine for the novel coronavirus has been developed that is 91.27% effective. If public health officials present this information using the specific number, people are likely to think the vaccine is actually less effective than if it is presented as being 90% effective.

7 Jul 2020